5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      GOLD 2023 Executive Summary: responses from the GOLD Scientific Committee

      letter

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We thank the authors of the five letters received in relation to the recent publication of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Executive Summary in the European Respiratory Journal [1] for their interest and insightful comments. We address them below, albeit necessarily briefly, under three categories: a global perspective, diagnostic issues, and management of exacerbations.

          Abstract

          The GOLD Scientific Committee respond to five letters to the Editor in relation to the GOLD 2023 Executive Summary https://bit.ly/41wJzhk

          Related collections

          Most cited references20

          • Record: found
          • Abstract: found
          • Article: not found

          Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease.

          Chronic obstructive pulmonary disease (COPD) is thought to result from an accelerated decline in forced expiratory volume in 1 second (FEV1) over time. Yet it is possible that a normal decline in FEV1 could also lead to COPD in persons whose maximally attained FEV1 is less than population norms.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis

            Summary Background Chronic obstructive pulmonary disease (COPD) is an increasingly important cause of morbidity, disability, and mortality worldwide. We aimed to estimate global, regional, and national COPD prevalence and risk factors to guide policy and population interventions. Methods For this systematic review and modelling study, we searched MEDLINE, Embase, Global Health, and CINAHL, for population-based studies on COPD prevalence published between Jan 1, 1990, and Dec 31, 2019. We included data reported using the two main case definitions: the Global Initiative for Chronic Obstructive Lung Disease fixed ratio (GOLD; FEV1/FVC<0·7) and the lower limit of normal (LLN; FEV1/FVC
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

              Executive summary of the Global Strategy for Prevention, Diagnosis and Management of COPD 2023: the latest evidence-based strategy document from the Global Initiative for Chronic Obstructive Lung Disease (GOLD ) https://bit.ly/3KCaTGe
                Bookmark

                Author and article information

                Journal
                Eur Respir J
                Eur Respir J
                ERJ
                erj
                The European Respiratory Journal
                European Respiratory Society
                0903-1936
                1399-3003
                June 2023
                15 June 2023
                : 61
                : 6
                : 2300616
                Affiliations
                [1 ]Univ. Barcelona, Hospital Clinic, IDIBAPS and CIBERES, Barcelona, Spain
                [2 ]South Texas Veterans Health Care System, University of Texas, San Antonio, TX, USA
                [3 ]Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA
                [4 ]Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK
                [5 ]National Heart and Lung Institute, Imperial College London, London, UK
                [6 ]School of Clinical Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
                [7 ]Pulmocare Research and Education (PURE) Foundation, Pune, India
                [8 ]Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University, German Center for Lung Research (DZL), Marburg, Germany
                Author notes
                Alvar Agustí ( aagusti@ 123456clinic.cat )
                Author information
                https://orcid.org/0000-0002-7266-8371
                https://orcid.org/0000-0002-8118-8871
                Article
                ERJ-00616-2023
                10.1183/13993003.00616-2023
                10269375
                37321613
                5c5d5b72-26c8-4d99-a631-f165076e0840
                Copyright ©The authors 2023.

                This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

                History
                : 12 April 2023
                : 21 April 2023
                Categories
                Correspondence

                Respiratory medicine
                Respiratory medicine

                Comments

                Comment on this article